Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

tirapazamine

A benzotriazine di-N-oxide with potential antineoplastic activity. Tirapazamine is selectively activated by multiple reductases to form free radicals in hypoxic cells, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. This agent also sensitizes hypoxic cells to ionizing radiation and inhibits the repair of radiation-induced DNA strand breaks via inhibition of topoisomerase II.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Tirazone
Code name:SR 4233
WIN 59075
Chemical structure:3-amino-1,2,4-benzotriazine-1,4-dioxide
IND number:46525
NSC code:130181
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search